Yanlu Xiong

1.9k total citations · 2 hit papers
42 papers, 1.3k citations indexed

About

Yanlu Xiong is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yanlu Xiong has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Cancer Research and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yanlu Xiong's work include RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (11 papers) and Ferroptosis and cancer prognosis (10 papers). Yanlu Xiong is often cited by papers focused on RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (11 papers) and Ferroptosis and cancer prognosis (10 papers). Yanlu Xiong collaborates with scholars based in China, United States and Japan. Yanlu Xiong's co-authors include Yong Han, Lintao Jia, Yangbo Feng, Tianyun Qiao, Xiaofei Li, Jinbo Zhao, Tao Jiang, Yujian Liu, Xiyang Tang and Kaifu Zheng and has published in prestigious journals such as Cancer Research, Medicine & Science in Sports & Exercise and Frontiers in Immunology.

In The Last Decade

Yanlu Xiong

40 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy

2018 480 citations Yangbo Feng, Yanlu Xiong et al. profile →
Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer

2022 124 citations Xiyang Tang, Yanlu Xiong et al. Frontiers in Immunology profile →

Peers

Countries citing papers authored by Yanlu Xiong

Since Specialization

Citations

This map shows the geographic impact of Yanlu Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanlu Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanlu Xiong more than expected).

Fields of papers citing papers by Yanlu Xiong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanlu Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanlu Xiong. The network helps show where Yanlu Xiong may publish in the future.

Co-authorship network of co-authors of Yanlu Xiong

This figure shows the co-authorship network connecting the top 25 collaborators of Yanlu Xiong. A scholar is included among the top collaborators of Yanlu Xiong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanlu Xiong. Yanlu Xiong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Highly proliferating cancer cells function as novel prognostic biomarkers for lung adenocarcinoma with particular usefulness for stage IA risk stratification 2025 ·BMC Cancer ·Yanlu Xiong, Yongfu Ma, Jie Lei, Jianfei Zhu, (unknown), Feng Tian, Qiang Lü, (unknown), (unknown), Yong Han, Tao Jiang, Yang Liu	1
2	CENPF (+) cancer cells promote malignant progression of early-stage TP53 mutant lung adenocarcinoma 2025 ·Oncogenesis ·Yanlu Xiong, Jie Lei, (unknown), Yongfu Ma, Jinbo Zhao, (unknown), (unknown), (unknown), Jianfei Zhu, Wenchen Wang, Xiaohong Ji, Ying Sun, (unknown), Jiao Zhang, (unknown), Yang Liu, Lintao Jia, Yong Han, Tao Jiang	1
3	Impact of histopathological subtypes on invasive lung adenocarcinoma: from epidemiology to tumour microenvironment to therapeutic strategies 2025 ·World Journal of Surgical Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Fancheng Meng, Yanlu Xiong, Yong Han	0
4	TCF19 promotes cell proliferation and tumor formation in lung cancer by activating the Raf/MEK/ERK signaling pathway 2024 ·Translational Oncology ·(unknown), (unknown), (unknown), (unknown), Lu Liu, (unknown), Tian Li, Fujun Peng, Yanlu Xiong, Yong Han	9
5	Early postoperative endoscopy for predicting anastomotic leakage after minimally invasive esophagectomy: A large-volume retrospective study 2024 ·Surgery ·(unknown), Jianfei Zhu, (unknown), Yang Shen, Yanlu Xiong, Kaifu Zheng, Xiyang Tang, Ling Wang, Yunfeng Ni, Tao Jiang, (unknown)	1
6	Precise diagnosis and prognosis assessment of malignant lung nodules: a narrative review 2024 ·Journal of Thoracic Disease ·(unknown), Q. Zheng, Xiao-Hong Ji, (unknown), (unknown), (unknown), (unknown), Jiao Zhang, Jie Yang, (unknown), Yanlu Xiong	2
7	Association between genetically proxied glucosamine and risk of cancer and non-neoplastic disease: A Mendelian randomization study 2024 ·Frontiers in Genetics ·(unknown), (unknown), Yong Zhang, Yanlu Xiong, (unknown), Jun Jiang, (unknown), Lin Guo, Tianyun Qiao, (unknown), Li Ou, (unknown), Xinxin Zhang, Minzhe Zhang, Dan Qiu, (unknown), (unknown), Xiangxiang Chen, Mingxiang Ye, Jian Zhang	1
8	Circulating tumor DNA minimal residual disease in clinical practice of non-small cell lung cancer 2023 ·Expert Review of Molecular Diagnostics ·(unknown), Jiao Zhang, Yanlu Xiong, Jinbo Zhao, (unknown), Tao Jiang, Jianfei Zhu	3
9	Recapitulating essential pathophysiological characteristics in lung-on-a-chip for disease studies 2023 ·Frontiers in Immunology ·Yanning Zhang, Xuejiao Wang, Yaoqing Yang, Jing Yan, Yanlu Xiong, Wenchen Wang, Jie Lei, Tao Jiang	17
10	Development and validation of a gene-based classification model for pN2 lung adenocarcinoma 2023 ·Translational Lung Cancer Research ·Jianfei Zhu, Wenchen Wang, Yu Ma, Jinbo Zhao, Yanlu Xiong	1
11	Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1–FGL1–MYH9 axis 2022 ·Frontiers in Immunology ·Xiyang Tang, Yanlu Xiong, (unknown), (unknown), (unknown), Kaifu Zheng, Yujian Liu, Chen Shu, Tao Jiang, Nan Ma, Jinbo Zhao	19
12	Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model 2022 ·Cancer Immunology Immunotherapy ·Tianyun Qiao, Jinbo Zhao, (unknown), Yanlu Xiong, Wenwen Guo, Fancheng Meng, Hui Li, Yangbo Feng, Hui Xu, Changhong Shi, (unknown)	12
13	The downregulation of fibrinogen-like protein 1 inhibits the proliferation of lung adenocarcinoma via regulating MYC-target genes 2022 ·Translational Lung Cancer Research ·Xiyang Tang, Yanlu Xiong, (unknown), Ying Sun, Qing Han, Yao Lv, (unknown), Milo Frattini, Jyoti Malhotra, Kaifu Zheng, Yujian Liu, Tao Jiang, Nan Ma, Jinbo Zhao	10
14	The Proliferative Role of Immune Checkpoints in Tumors: Double Regulation 2022 ·Cancers ·Xiyang Tang, (unknown), Yanlu Xiong, (unknown), (unknown), Kaifu Zheng, Yujian Liu, Shuqing Chen, Nan Ma, Qiang Lü, Jinbo Zhao	14
15	PD-L1 expression and immune cells infiltration in primary tracheobronchial neoplasm 2021 ·Translational Lung Cancer Research ·Kaifu Zheng, Yujian Liu, Nan Ma, Yanlu Xiong, Xiyang Tang, Qian Zhang, (unknown), (unknown), Paul Hofman, Yoshinobu Ichiki, Giulio Metro, Motoko Tachihara, Li Gong, Xiaofei Li, Jinbo Zhao	6
16	A gene-based survival score for lung adenocarcinoma by multiple transcriptional datasets analysis 2020 ·BMC Cancer ·Yanlu Xiong, Jie Lei, Jinbo Zhao, Qiang Lü, Yangbo Feng, Tianyun Qiao, (unknown), Yong Han, Tao Jiang	6
17	<p>Aberrantly High Expression Of NOK/STYK1 Is Tightly Associated With The Activation Of The AKT/GSK3β/N-Cadherin Pathway In Non-Small Cell Lung Cancer</p> 2019 ·OncoTargets and Therapy ·(unknown), Nan Ma, Yanlu Xiong, Lei Wang, Weimiao Li, (unknown), Chenxi Zhang, Zhipei Zhang, Xiaofei Li, Jinbo Zhao	8
18	Flexibility in metabolism bestows tenacious viability on cancer 2018 ·Life Sciences ·Yanlu Xiong, Lei Wang, Yangbo Feng, Xiaofei Li, Lintao Jia, Yong Han	2
19	Nkx2-2as Suppression Contributes to the Pathogenesis of Sonic Hedgehog Medulloblastoma 2017 ·Cancer Research ·Yimeng Zhang, Ting Wang, Shan Wang, Yanlu Xiong, Rui Zhang, Xiang Zhang, Jing Zhao, Angang Yang, Lei Wang, Lintao Jia	34
20	SIRT3 deacetylates and promotes degradation of P53 in PTEN-defective non-small cell lung cancer 2017 ·Journal of Cancer Research and Clinical Oncology ·Yanlu Xiong, Lei Wang, Shan Wang, Mingxing Wang, Jinbo Zhao, Zhipei Zhang, Xiaofei Li, Lintao Jia, Yong Han	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact